Gaia Martina Sarcinelli, Luca Varinelli, Silvia Ghislanzoni, Francesco Padelli, Daniele Lorenzini, A. Vingiani, Massimo Milione, Marcello Guagliò, Shigeki Kusamura, Marcello Deraco, Giancarlo Pruneri, Manuela Gariboldi, Dario Baratti, Italia Bongarzone,
Even with systemic chemotherapy, cytoreductive surgery (CRS), and hyperthermic intraperitoneal chemotherapy (HIPEC), peritoneal metastases (PM) remain a common site of disease progression for colorectal cancer (CRC) and are frequently associated with a poor prognosis. The mass spectrometry (MS) method known as Matrix-Assisted Laser Desorption/Ionization - Time of Flight (MALDI-TOF) is frequently used in medicine to identify structural compounds and biomarkers. It has been demonstrated that lipids are crucial ...
Tópico(s): Hepatocellular Carcinoma Treatment and Prognosis
2024 - BioMed Central | Cancer & Metabolism